| Neurodevelopmental outcomes of prenatal preeclampsia exposure SB Gumusoglu, ASS Chilukuri, DA Santillan, MK Santillan, HE Stevens Trends in neurosciences 43 (4), 253-268, 2020 | 134 | 2020 |
| Chronic maternal interleukin-17 and autism-related cortical gene expression, neurobiology, and behavior SB Gumusoglu, BWQ Hing, ASS Chilukuri, JJ Dewitt, SM Scroggins, ... Neuropsychopharmacology 45 (6), 1008-1017, 2020 | 38 | 2020 |
| Altered offspring neurodevelopment in an arginine vasopressin preeclampsia model SB Gumusoglu, ASS Chilukuri, BWQ Hing, SM Scroggins, S Kundu, ... Translational psychiatry 11 (1), 79, 2021 | 19 | 2021 |
| Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants N Jovanovich, A Habib, A Chilukuri, NUF Hameed, H Deng, R Shanahan, ... Frontiers in Oncology 13, 1340386, 2024 | 8 | 2024 |
| Subdural electrodes versus stereoelectroencephalography for pediatric epileptogenic zone localization: a retrospective cohort study M Remick, E Akwayena, E Harford, A Chilukuri, GE White, TJ Abel Neurosurgical Focus 53 (4), E4, 2022 | 5 | 2022 |
| Insulo‐opercular stereoelectroencephalography exploration in children and young adults: Indications, techniques, and safety AS Chilukuri, E Awkwayena, TJ Abel Epilepsia Open 7 (4), 729-736, 2022 | 2 | 2022 |
| An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma SM Casillo, TA Gatesman, A Chilukuri, S Varadharajan, BJ Johnson, ... Cell Reports 43 (1), 2024 | 1 | 2024 |
| DIPG-46. TARGETING THE METABOLIC ERK5-PFKFB3 AXIS IN PEDIATRIC DIFFUSE MIDLINE GLIOMA S Casillo, T Gatesman, A Chilukuri, E Jane, D Premkumar, C Barber, ... Neuro-Oncology 25 (Supplement_1), i23-i24, 2023 | 1 | 2023 |
| Pediatric Arteriovenous Malformation-Associated Aneurysms: The 35-Year Pittsburgh Experience RC Jacobs, A Chilukuri, H Abou-Al-Shaar, JH Garcia, P Agarwal, ... Journal of Neurological Surgery Part B: Skull Base 86 (S 01), S352, 2025 | | 2025 |
| TMET-39. DUAL TARGETING OF MAP KINASE SIGNALING AND METABOLISM IS A THERAPEUTIC VULNERABILITY IN PEDIATRIC DIFFUSE MIDLINE GLIOMAS T Gatesman, S Casillo, A Chilukuri, S Varadharajan, D Premkumar, ... Neuro-Oncology 26 (Supplement_8), viii296-viii296, 2024 | | 2024 |
| Arteriovenous malformation–associated aneurysms in the pediatric population: the University of Pittsburgh Medical Center experience RC Jacobs, A Chilukuri, H Abou-Al-Shaar, JH Garcia, P Agarwal, ... Journal of Neurosurgery: Pediatrics 1 (aop), 1-6, 2024 | | 2024 |
| 8263 Long-term Imaging Follow-up of Non-functioning Pituitary Adenomas N Mehrotra, MM Ross, AS Chilukuri, S Eljamri, C Ewing, S Patel, V Patel, ... Journal of the Endocrine Society 8 (Supplement_1), bvae163. 1268, 2024 | | 2024 |
| DIPG-79. METTL16 AS A THERAPEUTIC VULNERABILITY IN H3K27M MUTANT DMG CELLS A Chilukuri, M Pomaville, M Halbert, C He, S Agnihotri Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| DIPG-36. H3K27M HISTONE MUTANT GLIOMAS ARE SENSITIVE TO METHIONINE LOSS AND MAT2A INHIBITION THROUGH A NOVEL FEEDBACK MECHANISM BETWEEN AMD1 AND METTL16 A Chilukuri, M Halbert, B Golbourn, S Varadharajan, B Krug, N Mbah, ... Neuro-Oncology 25 (Supplement_1), i21-i21, 2023 | | 2023 |
| Insulo-opercular stereoelectroencephalog-raphy exploration in children: Indications, Techniques, and Safety A Chilukuri, E Akwayena, T Abel EPILEPSIA 62, 193-194, 2021 | | 2021 |
| Preeclampsia and Risk for Neurodevelopmental Disorders: Mouse Model Insights Into IL17 and Placental Function B Gumusoglu, A Chilukuri, S Scroggins, B Hing, J DeWitt, S Kundu, ... Biological Psychiatry 89 (9), S65-S66, 2021 | | 2021 |
| " Chronic maternal interleukin-17 and autism-related cortical gene expression, neurobiology, and behavior": Correction. SB Gumusoglu, BWQ Hing, ASS Chilukuri, JJ Dewitt, SM Scroggins, ... Nature Publishing Group, 2020 | | 2020 |
| Critical, Sex-Dependent Impacts of a Vasopressin Model of Preeclampsia on Neurodevelopment and Behavior in Mouse Offspring S Gumusoglu, A Chilukuri, S Haider, S Scroggins, J Sandgren, ... NEUROPSYCHOPHARMACOLOGY 43, S155-S155, 2018 | | 2018 |
